Lucas Paglia
Advertisement
Lucas is a partner and associate in Kirkpatrick & Lockhart, www.kl.com, a national law firm experienced in complex commercial litigation, intellectual property enforcement, and regulatory practice
Articles by Lucas Paglia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
2
Pharmaceutical Executive Daily: WHO Identifies Priority Treatment Candidates for Ebola
3
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms
4
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
5
